Figure 4.
Schematic representing a chemotherapeutic drug approach to targeting cancer stem cells (CSCs) as a potential treatment for cancer. Salinomycin has shown specific preclinical activity against CSCs. Reproduced with permission from https://www.mdpi.com/2673-8937/3/2/16 [91]. Accessed on 20 December 2024.
